Aesica appoints new European Manager

Aesica Pharmaceuticals has announced the appointment of Nicolas Micheaud as Regional Sales Manager – Western Europe, to promote the full range of Aesica contract development and manufacturing services.

Thirty-three year old Nicolas has ten years experience in the pharmaceutical industry working with companies to develop their businesses globally across Europe, Asia and the Middle East. Starting his career at SPI Pharma in France as a Product Manager and Sales Manager, Nicolas increased sales by 15 per cent. He then joined Goldshield working with Northern European and UK based customers before joining Cenexi as Business Developer, developing new business streams and orders worth €30million.

Nicolas said of his new appointment: “I am very excited to be joining Aesica at this time, as it is a rapidly growing company aiming to be the world’s leading supplier of Active Pharmaceutical Ingredients and Formulated Products. Aesica has a real spirit of partnership with their customers and this role will suit my skills and experience, as I’m a great problem solver and am committed to building long-term relationships. I have a wealth of experience in driving businesses forward and increasing sales, so am looking forward to this new challenge.”

Dr. Alan Raymond, Sales & Marketing Director, Aesica, said: “Nicolas joins the international sales and marketing team at an exciting and crucial stage of its development, as we recently doubled our global capabilities following our expansion into Europe. Nicolas’s experience and knowledge of the market will be invaluable and we are looking forward to working with him across Western Europe.”

Nicolas will be based in France, and work closely with each of Aesica’s three business units: API, R5, Formulation Development and Formulated Products.

Aesica is a leading full-serviceprovider of contract research, development and manufacturing services for Formulated Products and Active Pharmaceutical Ingredients. The company develops long-term strategic partnerships with its clients, responds quickly and effectively to market demand and develops tailored solutions for specific requirements.

Its unique proposition lies in its flexible and bespoke approach to service delivery, coupled with its ability to develop products from the initial clinical stage through to final commercial supply. Furthermore, the long established and proven expertise within Aesica enables it to provide primary and secondary contract manufacturing services to the highest possible regulatory standards. It is this full-service offer, its dedication to exceptional standards of service and its ability to deliver innovation and added value for its clients that truly sets Aesica apart from its counterparts.

For more information about Aesica please visit www.aesica-pharma.com